[1]
A. Chiricozzi, A. Costanzo, A. Levi, F. Parretta, and R. Ravasio, “Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy”, Grhta, vol. 11, no. 1, pp. 38–50, Feb. 2024.